Converting enzyme inhibition and the common carotid circulation in older patients with sustained essential

M Safar1, R Asmar, J Bouthier

  • 1Diagnosis Centre, Hopital Broussais, Paris, France.

Insights

Essential hypertension alters carotid artery blood flow and resistance, especially in older adults. Converting enzyme inhibitors effectively reversed these vascular abnormalities, improving circulation.

Area of Science:

  • Cardiovascular Medicine
  • Hypertension Research
  • Vascular Physiology

Background:

  • Sustained essential hypertension is a common condition affecting vascular health.
  • Understanding alterations in large and small arteries is crucial for managing hypertension.
  • The common carotid artery serves as a key site for vascular assessment.

Purpose of the Study:

  • To investigate arterial diameter, blood flow, and vascular resistance in the common carotid artery of patients with essential hypertension.
  • To compare these parameters between hypertensive patients and age-matched normal subjects.
  • To evaluate the effects of converting enzyme inhibitors on carotid circulation in hypertensive individuals.

Main Methods:

  • Utilized pulsed Doppler system for non-invasive assessment of arterial hemodynamics.
  • Studied patients with uncomplicated sustained essential hypertension and age-matched controls.
  • Administered converting enzyme inhibitors orally to assess acute and long-term effects.

Main Results:

  • Hypertensive patients below 45 years showed increased vascular resistance but normal arterial diameter and blood flow.
  • Hypertensive patients over 45 years exhibited reduced blood flow and markedly increased vascular resistance, with normal arterial diameter.
  • Converting enzyme inhibitors induced arterial dilatation, increased blood flow, and decreased vascular resistance, particularly in older hypertensive patients.

Conclusions:

  • Sustained essential hypertension impacts both small and large arteries in the common carotid circulation.
  • Converting enzyme inhibition demonstrates efficacy in reversing vascular abnormalities associated with hypertension, especially in older individuals.
  • This suggests a potential therapeutic benefit of converting enzyme inhibitors in managing hypertensive vascular disease.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.8K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
2.1K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.8K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
891